VBI Vaccines Inc. Profile Avatar - Palmy Investing

VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-26…

Biotechnology
US, Cambridge [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
VBI Vaccines Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
28,682,300
Volume
27,931,464
Volume on Avg.
8,393,583
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $0.07 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Dewilde Michel
Internal : Director
0 $0
01/31/22
0 x $0 = $0
Braga Damian
Internal : Director
0 $0
01/31/22
0 x $0 = $0
Baxter Jeff
Internal : CEO, President
0 $0
01/31/22
0 x $0 = $0
Cordeiro Joanne
Internal : Director
0 $0
01/30/23
0 x $0 = $0
Beattie Nell
Internal : CFO, Head of Corp. Development
0 $0
01/31/22
0 x $0 = $0
Himes Vaughn B
Internal : Director
0 $0
04/25/23
0 x $0 = $0
Mazaltov Avi
Internal : Head Global MFG&GM-SciVac Ltd.
0 $0
01/30/23
0 x $0 = $0
Diaz-Mitoma Francisco
Internal : Chief Medical Officer
0 $0
01/31/22
0 x $0 = $0
Gillis Steven
Internal : Director
0 $0
07/28/23
0 x $0 = $0
Dillman John Robert
Internal : Chief Commercial Officer
0 $0
07/28/23
0 x $0 = $0
Mckee Blaine H.
Internal : Director
0 $0
07/28/23
0 x $0 = $0
Anderson David Evander
Internal : Chief Scientific Officer
0 $0
01/31/22
0 x $0 = $0
Mcnulty Christopher
Internal : CFO and Head of BD
0 $0
01/30/23
0 x $0 = $0
Bain Linda
Internal : Director
0 $0
07/07/21
0 x $0 = $0
End of VBIV's Analysis
CIK: 764195 CUSIP: 91822J103 ISIN: CA91822J2020 LEI: - UEI: -
Secondary Listings
VBIV has no secondary listings inside our databases.